Search results for: Alain Ravaud
Items from 101 to 101 out of 101 results
Add recipient
Filter options
Publication date
- Set your own date range
Date range setting
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.
From:
To:
Keywords
- RENAL CELL CARCINOMA (19)
- EVEROLIMUS (14)
- SUNITINIB (13)
- METASTATIC RENAL CELL CARCINOMA (12)
- TARGETED THERAPY (8)
- SORAFENIB (6)
- ADVERSE EVENTS (5)
- BEVACIZUMAB (5)
- PHARMACOKINETICS (5)
- TYROSINE KINASE INHIBITOR (5)
- AXITINIB (4)
- CANCER (4)
- CHEMOTHERAPY (4)
- IMMUNOTHERAPY (4)
- PHASE I (4)
- COHORT STUDIES (3)
- DOCETAXEL (3)
- INTERLEUKIN-2 (3)
- KIDNEY CANCER (3)
- METASTATIC (3)
- MOLECULAR TARGETED THERAPY (3)
- MTOR INHIBITOR (3)
- PROSTATE CANCER (3)
- RESISTANCE (3)
- SAFETY (3)
- SEQUENTIAL THERAPY (3)
- TEMSIROLIMUS (3)
- TYROSINE KINASE INHIBITORS (3)
- TYROSINE KINASE RECEPTORS (3)
- #KIDNEYCANCER (2)
- ADJUVANT (2)
- ADVANCED RENAL CELL CARCINOMA (2)
- CARCINOMA (2)
- CLEAR CELL RENAL CELL CARCINOMA (2)
- COLORECTAL NEOPLASMS (2)
- DEPRESSIVE SYMPTOMS (2)
- ELDERLY PEOPLE (2)
- INTERFERON (2)
- LAPATINIB (2)
- METASTASIS (2)
- MTOR INHIBITORS (2)
- NEPHRECTOMY (2)
- PHASE 3 (2)
- PROGNOSTIC FACTORS (2)
- RENAL CELL (2)
- SOLID TUMOURS (2)
- SURVIVAL (2)
- TARGETED AGENTS (2)
- VEGF-R TARGETED THERAPY (2)
- #KCSM (1)
- #UROONC (1)
- ABLATIVE THERAPY (1)
- ADVANCED SOLID TUMOURS (1)
- ADVANCED/METASTATIC SOLID TUMOURS (1)
- AGED (1)
- ALKALINE PHOSPHATASE (1)
- ALTERNATING SCHEDULES (1)
- AMG 386 (1)
- ANGIOGENESIS (1)
- ANO1 (1)
- ANTICANCER THERAPY (1)
- ASSOCIATION OF AES AND CLINICAL EFFICACY (1)
- ATEZOLIZUMAB (1)
- AVELUMAB (1)
- BIOMARKERS (1)
- BLADDER CANCER (1)
- BLADDER NEOPLASM (1)
- CASE REPORTS (1)
- CD3E (1)
- CETUXIMAB (1)
- CHICK EMBRYO (1)
- CHS 828 (1)
- CLASS EFFECTS OF MTOR INHIBITION (1)
- CLEAR CELL METASTATIC RENAL CELL CARCINOMA (1)
- COMPLETE RESPONSE (1)
- COMPLICATION (1)
- COMPREHENSIVE GERIATRIC ASSESSMENT (1)
- CYTOKINE NETWORK (1)
- CYTOKINE TREATMENT (1)
- CYTOKINES (1)
- DAY-CASE (1)
- DEPRESSION (1)
- DIPEPTIDYL PEPTIDASE IV (1)
- DIRECTED ACYCLIC GRAPH (1)
- DISEASE-FREE SURVIVAL (1)
- DOSE ESCALATION (1)
- DOSING (1)
- EFFICACY (1)
- EFSPI SIG ESTIMANDS IN ONCOLOGY (1)
- EGF (1)
- EGFR (1)
- ELDERLY (1)
- EORTC (1)
- EPIDERMAL GROWTH FACTOR RECEPTOR (1)
- ERLOTINIB (1)
- ERYTHEMA (1)
- ESTIMAND (1)
- ESTRAMUSTINE (1)
- FLUORESCENT IN SITU HYBRIDISATION (1)
- FRAIL ELDERLY (1)
- more
Data set
Journal
- European Journal of Cancer (11)
- European Urology (9)
- The Journal of Urology (9)
- BJU International (5)
- Cancer Treatment Reviews (5)
- Clinical Genitourinary Cancer (5)
- EJC Supplements (5)
- Targeted Oncology (5)
- European Urology Supplements (4)
- The Lancet (4)
- The Lancet Oncology (4)
- Urologic Oncology: Seminars and Original Investigations (4)
- Urology (4)
- World Journal of Urology (4)
- British Journal of Clinical Pharmacology (2)
- Cancer (2)
- Oral Oncology (2)
- Angiogenesis (1)
- Asia‐Pacific Journal of Clinical Oncology (1)
- BMC Cancer (1)
- Brain Behavior and Immunity (1)
- CardioVascular and Interventional Radiology (1)
- Clinical Pharmacokinetics (1)
- Critical Reviews in Oncology / Hematology (1)
- Current Urology Reports (1)
- International Journal of Urology (1)
- Journal for ImmunoTherapy of Cancer (1)
- Journal of Geriatric Oncology (1)
- Neuropsychopharmacology (1)
- Pharmaceutical Statistics (1)
- Pharmacoepidemiology and Drug Safety (1)
- Psychoneuroendocrinology (1)
- Supportive Care in Cancer (1)
- The Lancet Infectious Diseases (1)
- more